摘要
光学分子成像常用于包括癌症检查、肿瘤机制研究、药效评价和靶向给药在内的许多临床前研究。在光学分子成像的形式中,生物发光成像和荧光成像已取得一定发展,并且因为高灵敏度和低成本取得了越来越的的关注。随着光学技术和探测技术的发展,双光子显微成像和拉曼成像已广泛用于通过细胞和组织成像进行的药物评价和肿瘤研究。这篇文章重点讲述了光学分子成像的发生和发展,尤其重点讲述了它的成像方法,成像系统和靶向给药的应用。最后,我们讨论了目前的挑战和光学成像在药物投递研究中的新应用。
关键词: 光学分子成像,靶向给药,生物发光成像,荧光成像,双光子显微成像,拉曼成像。
Current Drug Targets
Title:Recent Advances in Optical Molecular Imaging and its Applications in Targeted Drug Delivery
Volume: 16 Issue: 6
Author(s): Xibo Ma, Hui Hui, Wenting Shang, Xiaohua Jia, Xin Yang and Jie Tian
Affiliation:
关键词: 光学分子成像,靶向给药,生物发光成像,荧光成像,双光子显微成像,拉曼成像。
摘要: Optical molecular imaging has been frequently used in many preclinical researches including cancer detection, tumor mechanism study, drug efficacy evaluation and targeted drug delivery. Among optical molecular imaging modalities, bioluminescence imaging and fluorescence imaging have acquired certain degree of development and attracted more and more attention in recent years for their high sensitivity and low cost. With the development of optical technology and probe technology, two-photon microscopy imaging and Raman imaging have been widely used in drug evaluation and tumor studies through cell and tissue imaging. This paper focuses on the occurrence and development of optical molecular imaging especially for its imaging method imaging system and its application in target drug delivery. Finally, the existing challenges and brand new applications of optical imaging techniques in drug delivery research are discussed.
Export Options
About this article
Cite this article as:
Xibo Ma, Hui Hui, Wenting Shang, Xiaohua Jia, Xin Yang and Jie Tian , Recent Advances in Optical Molecular Imaging and its Applications in Targeted Drug Delivery, Current Drug Targets 2015; 16 (6) . https://dx.doi.org/10.2174/1389450116666150102112747
DOI https://dx.doi.org/10.2174/1389450116666150102112747 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Natural Products Targeting Cancer Stem Cells: A Revisit
Current Medicinal Chemistry Apoptosis Induction by Erucylphosphohomocholine via the 18 kDa Mitochondrial Translocator Protein: Implications for Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer
Current Pharmaceutical Design Anticancer Agents Derived from Natural Cinnamic Acids
Anti-Cancer Agents in Medicinal Chemistry The 18 kDa Mitochondrial Translocator Protein (TSPO) Prevents Accumulation of Protoporphyrin IX. Involvement of Reactive Oxygen Species (ROS)
Current Molecular Medicine Aquaporins and Glia
Current Neuropharmacology Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Recent Patents on Anti-Cancer Drug Discovery Inhibitors of HDACs - Effective Drugs Against Cancer?
Current Cancer Drug Targets Withdrawal Notice: The Recent Advancement in the Field of Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) for Aiming Breast Cancer
Current Drug Metabolism Herbal Compounds with Special Reference to Gastrodin as Potential Therapeutic Agents for Microglia Mediated Neuroinflammation
Current Medicinal Chemistry Pyruvate Kinase M2: Regulatory Circuits and Potential for Therapeutic Intervention
Current Pharmaceutical Design Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
Current Genomics Current Status on Natural Products with Antitumor Activity from Brazilian Marine Sponges
Current Pharmaceutical Biotechnology Mitochondrial Superoxide Dismutase - Signals of Distinction
Anti-Cancer Agents in Medicinal Chemistry Nifurtimox Hampered the Progression of Astroglioma <i>In vivo Via</i> Manipulating the AKT-GSK3β axis
Current Molecular Medicine The Role of Tumor-related LncRNA PART1 in Cancer
Current Pharmaceutical Design Immune Checkpoint Inhibitors: Basics and Challenges
Current Medicinal Chemistry Expression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis
Current Genomics An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Design Photo- and Sono-Dynamic Therapy: A Review of Mechanisms and Considerations for Pharmacological Agents Used in Therapy Incorporating Light and Sound
Current Pharmaceutical Design